Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2016
Deal or delay: NICE's new negotiating chip
20 October 2016 - With the UK's NHS facing a financial challenge that shows no signs of abating any time ...
Posted by Michael Wonder on 22 Oct 2016
Faster access to drugs
20 October 2016 - Dr Jacoline Bouvy, Scientific Adviser – IMI ADAPT-SMART, discusses how to bring new drugs to patients faster. ...
Posted by Michael Wonder on 21 Oct 2016
New treatment recommended for kidney cancer
20 October 2016 - People with kidney cancer set to benefit from a new innovative immunotherapy, after NICE says it should ...
Posted by Michael Wonder on 20 Oct 2016
Oral Otezla (apremilast) receives positive NICE recommendation for adults with chronic plaque psoriasis
20 October 2016 - Approved by NICE for patients with severe plaque psoriasis as defined by PASI and DLQI greater than ...
Posted by Michael Wonder on 18 Oct 2016
NICE proposes faster process to appraise cheaper drugs
18 October 2016 - The BMJ reports on the recently announced NICE reforms. ...
Posted by Michael Wonder on 18 Oct 2016
NICE publishes evaluation consultation document for for migalastat hydrochloride
18 October 2016 - NICE has published draft guidance on this highly specialised technology. ...
Posted by Michael Wonder on 14 Oct 2016
NICE publishes draft guidance on the use of Imbruvica
14 October 2016 - NICE has published draft guidance on the use of Imbruvica (ibrutinib) by patients with Waldenstrom’s macroglobulinaemia. ...
Posted by Michael Wonder on 14 Oct 2016
NICE publishes draft guidance on the use of Opdivo by patients with NSCLC
14 October 2016 - NICE has published draft guidance on the use of Opdivo (nivolumab) by patients with lung cancer. ...
Posted by Michael Wonder on 13 Oct 2016
Patients to get faster access to the most cost effective treatments under proposed changes to NICE's process
13 October 2016 - Patients could benefit from the most cost effective treatments nearly three months faster under plans unveiled by ...
Posted by Michael Wonder on 11 Oct 2016
Cost, effectiveness, and value. How to judge?
11 October 2016 - Former NICE Chairman Sir Michael Rawlins offers his views in JAMA. ...
Posted by Michael Wonder on 11 Oct 2016
NICE publishes draft guidance on the use of Otezla on the NHS
11 October 2016 - NICE has published draft guidance on the use of Otelza (apremilast) on the NHS by patients ...
Posted by Michael Wonder on 09 Oct 2016
NICE backs use of Forxiga in triple therapy for diabetes
7 October 2016 - NICE has now published final draft guidelines endorsing NHS use of AstraZeneca's Forxiga for treating type ...
Posted by Michael Wonder on 09 Oct 2016
Thousands of European melanoma patients lack access to new drugs
7 October 2016 - More than a quarter of European patients with advanced melanoma lack access to new treatments that ...
Posted by Michael Wonder on 04 Oct 2016
NICE published draft guidance on a new use for Keytruda
4 October 2016 - NICE has published draft guidance on the use of Keytruda (pembrolizumab) by patients with non-small-cell lung ...
Posted by Michael Wonder on 04 Oct 2016
NICE recommends new drug osimertinib for hundreds of people with lung cancer
4 October 2016 - Hundreds of people with lung cancer will now have access to new drug osimertinib, also known as ...